Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$4.51 - $6.6 $114,928 - $168,187
-25,483 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$5.16 - $6.85 $131,492 - $174,558
25,483 New
25,483 $159,000
Q4 2018

Feb 13, 2019

SELL
$4.89 - $7.16 $154,533 - $226,270
-31,602 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$6.89 - $7.78 $45,191 - $51,029
-6,559 Reduced 17.19%
31,602 $228,000
Q2 2018

Aug 14, 2018

BUY
$5.19 - $7.25 $100,343 - $140,171
19,334 Added 102.69%
38,161 $255,000
Q1 2018

May 15, 2018

BUY
$3.56 - $5.74 $67,024 - $108,066
18,827 New
18,827 $103,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $278M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.